Skip to main content
MDGL
NASDAQ Life Sciences

One-Year Rezdiffra Data Shows Liver Stiffness Improvement in Up to 93% of Patients

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$408.99
Mkt Cap
$9.501B
52W Low
$353.54
52W High
$615
52W Position info
16% above low
Off High info
33% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

MDGL sits 16% above its 52-week low of $353.54.

Summary

Madrigal released one-year data showing up to 93% of patients had improved or stabilized liver stiffness on Rezdiffra, with up to 72% still on the drug at one year and high adherence. Safety looked clean: only 11% had at least one adverse event, led by diarrhea at 7% and nausea at 4%, consistent with the established label profile. Improvements held regardless of GLP-1 use, and up to 53% of patients were on a GLP-1 — a useful rebuttal to the worry that GLP-1 drugs shrink Rezdiffra's addressable market. This lands two days after the company's first profitable quarter, $55.4 million of net income on $431.3 million of Rezdiffra sales, so it reinforces the durability story behind the launch rather than changing the near-term numbers.

At the time of this announcement, MDGL was trading at $408.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $353.54 to $615.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MDGL - Latest Insights

MDGL
Nov 06, 2026, 5:30 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $399.93
Real-time Price: $396.74 info
Change: -$3.19 (-0.80%) info
Market Cap: $9.216B info
MDGL
Nov 03, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $428.01
Real-time Price: $396.74 info
Change: -$31.27 (-7%) info
Market Cap: $9.216B info
MDGL
Nov 03, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $477.00
Real-time Price: $396.74 info
Change: -$80.26 (-17%) info
Market Cap: $9.216B info
MDGL
Nov 03, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $431.16
Real-time Price: $396.74 info
Change: -$34.41 (-8%) info
Market Cap: $9.216B info
MDGL
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $475.00
Real-time Price: $396.74 info
Change: -$78.26 (-16%) info
Market Cap: $9.216B info